OPKO Health Total Assets 2010-2024 | OPK

OPKO Health total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Assets
(Millions of US $)
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.990B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.930B 27.22
Intuitive Surgical (ISRG) United States $155.197B 87.88
Alcon (ALC) Switzerland $45.300B 32.45
DexCom (DXCM) United States $42.890B 61.63
IQVIA Holdings (IQV) United States $42.346B 24.00
IDEXX Laboratories (IDXX) United States $38.872B 45.56
Edwards Lifesciences (EW) United States $35.975B 23.05
STERIS (STE) Ireland $22.495B 26.28
Waters (WAT) United States $18.406B 27.05
Hologic (HOLX) United States $18.175B 20.33
SONOVA HOLDING (SONVY) Switzerland $17.783B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.965B 13.97
Teleflex (TFX) United States $10.480B 16.31
Sysmex ADR (SSMXY) Japan $9.774B 30.65
Globus Medical (GMED) United States $9.713B 28.47
Penumbra (PEN) United States $7.369B 83.74
Glaukos (GKOS) United States $5.926B 0.00
Masimo (MASI) United States $5.838B 33.57
TransMedics (TMDX) United States $4.809B 456.22
Integer Holdings (ITGR) United States $3.876B 22.68
PROCEPT BioRobotics (PRCT) United States $3.312B 0.00
Inari Medical (NARI) United States $3.209B 0.00
LivaNova (LIVN) United Kingdom $2.894B 17.19
Tandem Diabetes Care (TNDM) United States $2.626B 0.00
Integra LifeSciences Holdings (IART) United States $2.485B 10.84
Veracyte (VCYT) United States $1.816B 0.00
RxSight (RXST) United States $1.676B 0.00
Alphatec Holdings (ATEC) United States $1.521B 0.00
Artivion (AORT) United States $1.145B 109.84
Pulse Biosciences (PLSE) United States $1.084B 0.00
Silk Road Medical (SILK) United States $1.065B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.052B 20.46
OrthoPediatrics (KIDS) United States $0.783B 0.00
Paragon 28 (FNA) United States $0.718B 0.00
SiBone (SIBN) United States $0.658B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.620B 0.00
IRadimed (IRMD) United States $0.598B 33.51
Mesa Laboratories (MLAB) United States $0.585B 17.31
Pacific Biosciences Of California (PACB) United States $0.519B 0.00
Treace Medical Concepts (TMCI) United States $0.486B 0.00
AxoGen (AXGN) United States $0.408B 0.00
Sight Sciences (SGHT) United States $0.400B 0.00
Nevro (NVRO) United States $0.363B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.50
AngioDynamics (ANGO) United States $0.301B 0.00
Delcath Systems (DCTH) United States $0.242B 0.00
NeuroPace (NPCE) United States $0.234B 0.00
Inogen (INGN) United States $0.229B 0.00
Semler Scientific (SMLR) United States $0.227B 11.52
ClearPoint Neuro (CLPT) United States $0.207B 0.00
CVRx (CVRX) United States $0.206B 0.00
908 Devices (MASS) United States $0.191B 0.00
Accuray (ARAY) United States $0.186B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
EDAP TMS S.A (EDAP) France $0.174B 0.00
Alpha Tau Medical (DRTS) Israel $0.147B 0.00
KORU Medical Systems (KRMD) United States $0.114B 0.00
Sensus Healthcare (SRTS) United States $0.104B 21.86
Spectral Diagnostics (EDTXF) Canada $0.103B 0.00
T2 Biosystems (TTOO) United States $0.084B 0.00
Hyperfine (HYPR) United States $0.083B 0.00
Monogram Orthopaedics (MGRM) United States $0.079B 0.00
InspireMD (NSPR) Israel $0.074B 0.00
EnVVeno Medical (NVNO) United States $0.073B 0.00
LENSAR (LNSR) United States $0.061B 0.00
Neuronetics (STIM) United States $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Precision Optics (POCI) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Rapid Micro Biosystems (RPID) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.027B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Autonomix Medical (AMIX) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Pixie Dust Technologies (PXDT) Japan $0.019B 0.00
NexGel (NXGL) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00